FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130897032> ?p ?o ?g. }

• W2130897032 endingPage "1582" @default.
• W2130897032 startingPage "1576" @default.
• W2130897032 abstract "Esophageal adenocarcinoma (EAC) is a highly aggressive disease with poor long-term survival. Despite growing knowledge of its biology, no molecular biomarkers are currently used in routine clinical practice to determine prognosis or aid clinical decision making. Hence, this study set out to identify and validate a small, clinically applicable immunohistochemistry (IHC) panel for prognostication in patients with EAC.We recently identified eight molecular prognostic biomarkers using two different genomic platforms. IHC scores of these biomarkers from a UK multicenter cohort (N = 374) were used in univariate Cox regression analysis to determine the smallest biomarker panel with the greatest prognostic power with potential therapeutic relevance. This new panel was validated in two independent cohorts of patients with EAC who had undergone curative esophagectomy from the United States and Europe (N = 666).Three of the eight previously identified prognostic molecular biomarkers (epidermal growth factor receptor [EGFR], tripartite motif-containing 44 [TRIM44], and sirtuin 2 [SIRT2]) had the strongest correlation with long-term survival in patients with EAC. Applying these three biomarkers as an IHC panel to the validation cohort segregated patients into two different prognostic groups (P < .01). Adjusting for known survival covariates, including clinical staging criteria, the IHC panel remained an independent predictor, with incremental adverse overall survival (OS) for each positive biomarker (hazard ratio, 1.20; 95% CI, 1.03 to 1.40 per biomarker; P = .02).We identified and validated a clinically applicable IHC biomarker panel, consisting of EGFR, TRIM44, and SIRT2, that is independently associated with OS and provides additional prognostic information to current survival predictors such as stage." @default.
• W2130897032 created "2016-06-24" @default.
• W2130897032 creator A5005487497 @default.
• W2130897032 creator A5005631181 @default.
• W2130897032 creator A5006983831 @default.
• W2130897032 creator A5024335584 @default.
• W2130897032 creator A5027097085 @default.
• W2130897032 creator A5027622390 @default.
• W2130897032 creator A5030943165 @default.
• W2130897032 creator A5036724037 @default.
• W2130897032 creator A5038858116 @default.
• W2130897032 creator A5042830854 @default.
• W2130897032 creator A5050348689 @default.
• W2130897032 creator A5051165863 @default.
• W2130897032 creator A5051471434 @default.
• W2130897032 creator A5052658968 @default.
• W2130897032 creator A5073045992 @default.
• W2130897032 creator A5090498503 @default.
• W2130897032 date "2013-04-20" @default.
• W2130897032 modified "2023-10-14" @default.
• W2130897032 title "Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma" @default.
• W2130897032 cites W1979539656 @default.
• W2130897032 cites W1996277965 @default.
• W2130897032 cites W1998124363 @default.
• W2130897032 cites W1998974491 @default.
• W2130897032 cites W2037988871 @default.
• W2130897032 cites W2045090755 @default.
• W2130897032 cites W2048143418 @default.
• W2130897032 cites W2052758095 @default.
• W2130897032 cites W2058283286 @default.
• W2130897032 cites W2060374179 @default.
• W2130897032 cites W2061939383 @default.
• W2130897032 cites W2062641317 @default.
• W2130897032 cites W2066753630 @default.
• W2130897032 cites W2069755925 @default.
• W2130897032 cites W2074918415 @default.
• W2130897032 cites W2088947549 @default.
• W2130897032 cites W2091372427 @default.
• W2130897032 cites W2101095530 @default.
• W2130897032 cites W2104558660 @default.
• W2130897032 cites W2111674123 @default.
• W2130897032 cites W2134908923 @default.
• W2130897032 cites W2137359792 @default.
• W2130897032 cites W2143858250 @default.
• W2130897032 cites W2154664762 @default.
• W2130897032 cites W2160064816 @default.
• W2130897032 cites W2165948908 @default.
• W2130897032 cites W2168666498 @default.
• W2130897032 cites W2170740009 @default.
• W2130897032 cites W4254542795 @default.
• W2130897032 doi "https://doi.org/10.1200/jco.2012.45.9636" @default.
• W2130897032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3625712" @default.
• W2130897032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23509313" @default.
• W2130897032 hasPublicationYear "2013" @default.
• W2130897032 type Work @default.
• W2130897032 sameAs 2130897032 @default.
• W2130897032 citedByCount "67" @default.
• W2130897032 countsByYear W21308970322013 @default.
• W2130897032 countsByYear W21308970322014 @default.
• W2130897032 countsByYear W21308970322015 @default.
• W2130897032 countsByYear W21308970322016 @default.
• W2130897032 countsByYear W21308970322017 @default.
• W2130897032 countsByYear W21308970322018 @default.
• W2130897032 countsByYear W21308970322019 @default.
• W2130897032 countsByYear W21308970322020 @default.
• W2130897032 countsByYear W21308970322021 @default.
• W2130897032 countsByYear W21308970322022 @default.
• W2130897032 countsByYear W21308970322023 @default.
• W2130897032 crossrefType "journal-article" @default.
• W2130897032 hasAuthorship W2130897032A5005487497 @default.
• W2130897032 hasAuthorship W2130897032A5005631181 @default.
• W2130897032 hasAuthorship W2130897032A5006983831 @default.
• W2130897032 hasAuthorship W2130897032A5024335584 @default.
• W2130897032 hasAuthorship W2130897032A5027097085 @default.
• W2130897032 hasAuthorship W2130897032A5027622390 @default.
• W2130897032 hasAuthorship W2130897032A5030943165 @default.
• W2130897032 hasAuthorship W2130897032A5036724037 @default.
• W2130897032 hasAuthorship W2130897032A5038858116 @default.
• W2130897032 hasAuthorship W2130897032A5042830854 @default.
• W2130897032 hasAuthorship W2130897032A5050348689 @default.
• W2130897032 hasAuthorship W2130897032A5051165863 @default.
• W2130897032 hasAuthorship W2130897032A5051471434 @default.
• W2130897032 hasAuthorship W2130897032A5052658968 @default.
• W2130897032 hasAuthorship W2130897032A5073045992 @default.
• W2130897032 hasAuthorship W2130897032A5090498503 @default.
• W2130897032 hasBestOaLocation W21308970322 @default.
• W2130897032 hasConcept C121608353 @default.
• W2130897032 hasConcept C126322002 @default.
• W2130897032 hasConcept C142724271 @default.
• W2130897032 hasConcept C143998085 @default.
• W2130897032 hasConcept C185592680 @default.
• W2130897032 hasConcept C204232928 @default.
• W2130897032 hasConcept C207103383 @default.
• W2130897032 hasConcept C2777297899 @default.
• W2130897032 hasConcept C2779742542 @default.
• W2130897032 hasConcept C2781197716 @default.
• W2130897032 hasConcept C44249647 @default.
• W2130897032 hasConcept C50382708 @default.

• next